Clinical Trials
1
Active:0
Completed:0
Trial Phases
1 Phases
Phase 1:1
Drug Approvals
0
Drug Approvals
No drug approvals found
This company may not have drug approvals in our database
Clinical Trials
Distribution across different clinical trial phases (1 trials with phase data)• Click on a phase to view related trials
Phase 1
1 (100.0%)Controlled Trial of ABELADRUG200 in Closed, Severe Head Injury
- First Posted Date
- 2008-12-18
- Last Posted Date
- 2010-12-08
- Lead Sponsor
- Abela Pharmaceuticals, Inc.
- Target Recruit Count
- 30
- Registration Number
- NCT00810940
- Locations
- 🇺🇸
University of California, Irvine, Irvine, California, United States
🇺🇸Boston University Medical Center, Boston, Massachusetts, United States
🇺🇸Ohio State University, Columbus, Ohio, United States
News
No news found